Cambridge Investment Research Advisors
PRXL

Cambridge Investment Research Advisors’s Parexel International Corp PRXL Stock Holding History

Cambridge Investment Research Advisors’s Portfolio PRXL Stock Details PRXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-3,575
Closed -$235K – 1842
2016
Q4 		$235K Sell
3,575
-143
-4% -$8.97K ﹤0.01% 1416
2016
Q3 		$258K Buy
3,718
+151
+4% +$10.2K ﹤0.01% 1387
2016
Q2 		$224K Sell
3,567
-138
-4% -$8.54K ﹤0.01% 1329
2016
Q1 		$232K Buy
3,705
+476
+15% +$29.3K 0.01% 1322
2015
Q4 		$220K Buy
+3,229
New +$210K 0.01% 1315

Other funds holding PRXL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
AAM
Aberdeen Asset Management Aberdeen, United Kingdom $30B AUM 22.69% 1-Year Est. Return

Cambridge Investment Research Advisors's PRXL Position: Q1 2017 in Review

Cambridge Investment Research Advisors sold out of Parexel International Corp (PRXL) in Q1 2017, closing a stake of 3,575 shares — an estimated $235K sold.

Cambridge Investment Research Advisors first reported a position in PRXL in Q4 2015 and held it in 5 quarters. The position peaked at $258K in Q3 2016. 308 funds tracked by Wall St. Rank hold PRXL as of Q1 2017.

  • Cambridge Investment Research Advisors reported no remaining Parexel International Corp position as of Q1 2017 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 3,575 Parexel International Corp shares in Q1 2017, an estimated $235K.
  • Cambridge Investment Research Advisors first reported a position in Parexel International Corp in Q4 2015 and held it in 5 quarters.
  • Cambridge Investment Research Advisors's Parexel International Corp position peaked at $258K in Q3 2016.
  • 308 funds tracked by Wall St. Rank held Parexel International Corp as of Q1 2017.

Based on Cambridge Investment Research Advisors's 13F filing for Q1 2017, filed 12 May 2017.